Neurogenesis deficits in Down syndrome: testing recovery with GABAα5 negative allosteric modulator, β2 adrenergic agonist and IGF-1 in Ts65Dn mice

Autor:	Maria Elisa Salvalai, Marie-Claude Potier, Mariagrazia Grilli, Christelle Albac, Renata Bartesaghi, Fiorenza Stagni
Rok vydání:	2019
Předmět:	Pharmacology medicine.medical_specialty Down syndrome Allosteric modulator business.industry Neurogenesis medicine.disease Psychiatry and Mental health Endocrinology Neurology β2 adrenergic agonist Internal medicine Medicine Pharmacology (medical) Neurology (clinical) business Biological Psychiatry
Zdroj:	European Neuropsychopharmacology. 29:S445-S446
ISSN:	0924-977X
DOI:	10.1016/j.euroneuro.2018.11.670
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::641ac36100cf7d6d1a354fb4ef32faf3 https://doi.org/10.1016/j.euroneuro.2018.11.670 Zobrazit plný text záznamu Full Text from ScienceDirect